| Literature DB >> 27849402 |
Dawn Ching Wen Ho1, Aniruddha Agarwal2,3, Cecilia S Lee4, Jay Chhablani5, Vishali Gupta3, Manoj Khatri6, Jayabalan Nirmal7, Carlos Pavesio8, Rupesh Agrawal1,7,8,9.
Abstract
Infectious endophthalmitis is an important cause of vision loss worldwide. This entity most often occurs as a complication of intraocular surgery especially following cataract surgery or intravitreal injection. Endophthalmitis is regarded as a serious complication following ocular surgery and the final visual outcome is fundamentally contingent on timely recognition and intervention. Intravitreal and oral antibiotics in combination with pars plana vitrectomy or vitreous aspiration remain the mainstay in the management of endophthalmitis. However, significant inflammation may persist even after sterilization of the intraocular cavities with appropriate antibiotics resulting in failure of treatment. This forms the basis for the use of intravitreal corticosteroids as an adjuvant to antibiotics in the management of infectious endophthalmitis. In the index manuscript, we review the existing literature to determine the role of intravitreal corticosteroids as an adjuvant to antibiotics in treating infectious endophthalmitis, and discuss their beneficial effects and controversial concerns.Entities:
Keywords: Antibiotics; antifungals; corticosteroids; endophthalmitis; intravitreal steroids; intravitreal therapy; uveitis
Mesh:
Substances:
Year: 2016 PMID: 27849402 PMCID: PMC5557691 DOI: 10.1080/09273948.2016.1245758
Source DB: PubMed Journal: Ocul Immunol Inflamm ISSN: 0927-3948 Impact factor: 3.070